Chimerix Inc - Company Profile
Powered by
All the data and insights you need on Chimerix Inc in one report.
- Save hours of research time and resources with
our up-to-date Chimerix Inc Strategy Report
- Understand Chimerix Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Chimerix Inc (Chimerix) is a biopharmaceutical company. It develops, discovers, and commercializes novel and oral antiviral therapeutics. The company’s pipeline product portfolio includes ONC201, ONC206, ONC212, CMX521 drug candidates. Its products are used to treat various diseases like gliomas, central nervous system tumors, COVID-19 and IND-enabling studies. Its brincidofovir tablet and oral suspension formulations are used in the treatment of smallpox disease in adult and pediatric patients. The company markets its products under the brand name TEMBEXA. The organization works in partnership with Oncoceutics, Inc., Cantex Pharmaceuticals, BARDA, and SymBio Pharmaceuticals. Chimerix is headquartered in Durham, North Carolina, the US.
Chimerix Inc premium industry data and analytics
Products and Services
Products | Brands |
---|---|
Pipeline | TEMBEXA |
ONC201 (To Treat Gliomas) | |
ONC206 (To Treat Central Nervous System Tumors) | |
XYZ | |
XYZ | |
XYZ |
Competitor Comparison
Key Parameters | Chimerix Inc | Aclaris Therapeutics Inc | Scorpius Holdings Inc | DMK Pharmaceuticals Corp | Abeona Therapeutics Inc |
---|---|---|---|---|---|
Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
City | Durham | Wayne | Morrisville | San Diego | Cleveland |
State/Province | North Carolina | Pennsylvania | North Carolina | California | Ohio |
No. of Employees | 72 | 91 | 77 | 11 | 84 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Mike Sherman | Chairman | Executive Board | 2023 | - |
Mike Andriole | Chief Executive Officer; President | Senior Management | 2023 | - |
Michelle LaSpaluto | Chief Financial Officer | Senior Management | 2023 | - |
Roy W. Ware | Chief Technology Officer; Chief Manufacturing Officer | Senior Management | 2017 | - |
Joshua E. Allen | Chief Technology Officer | Senior Management | 2021 | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer